Identification of a Non-Retinoid Opsin Ligand Through Pharmacophore-Guided Virtual Screening-A Novel Potential...

Area of Science:

• Biochemistry
• Molecular Biology
• Ophthalmology

Background:

• Rhodopsin, a G-protein-coupled receptor, is crucial for vision.
• Mutations in rhodopsin cause retinal degenerative disorders like retinitis pigmentosa.
• Current retinoid-based therapies for mutant rhodopsin are limited by toxicity and instability.

Purpose of the Study:

• To identify novel non-retinoid pharmacological chaperones for opsin.
• To develop new stabilizers for mutant rhodopsin to treat retinal diseases.

Main Methods:

• Pharmacophore-based virtual screening.
• Molecular docking and molecular dynamics simulations.
• Biological validation of compound binding to opsin.

Main Results:

• Identification of a novel non-retinoid opsin ligand, VS1.
• VS1 effectively binds opsin, demonstrating potential as a pharmacological chaperone.
• VS1 represents a promising starting point for developing opsin stabilizers.

Conclusions:

• A novel non-retinoid compound, VS1, has been identified as an effective opsin binder.
• VS1 shows potential as a pharmacological chaperone for stabilizing opsin.
• This finding paves the way for structure-based drug design for retinal degenerative diseases.